View 
FILTERS (0)
* Not connected to ResearchPool

MORE FILTERS

  
reports
 PRESS RELEASE

Conifer Holdings Reports 2025 Second Quarter Financial Results

Conifer Holdings Reports 2025 Second Quarter Financial Results TROY, Mich., Aug. 13, 2025 (GLOBE NEWSWIRE) -- Conifer Holdings, Inc. (Nasdaq: CNFR) (“Conifer” or the “Company”) today announced results for the second quarter ended June 30, 2025. Second Quarter 2025 Financial Highlights Net income allocable to common shareholders of $2.1 million, or $0.17 per shareGains in the quarter due largely to valuation recognition of an earnoutNet investment income of $1.3 millionBook value increased to $2.31 per common share outstanding Management Comments Brian Roney, ...

 PRESS RELEASE

Middlefield Banc Corp. Announces 2025 Third-Quarter Cash Dividend Paym...

Middlefield Banc Corp. Announces 2025 Third-Quarter Cash Dividend Payment MIDDLEFIELD, Ohio, Aug. 11, 2025 (GLOBE NEWSWIRE) -- Middlefield Banc Corp. (NASDAQ: MBCN) today announced that its Board of Directors declared a quarterly cash dividend of $0.21 per common share. The 2025 third-quarter dividend is payable on September 12, 2025, to shareholders of record on August 29, 2025. About Middlefield Banc Corp. Middlefield Banc Corp., headquartered in Middlefield, Ohio, is the Bank holding Company of The Middlefield Banking Company, with total assets of $1.92 billion at June 30, 2025. The...

 PRESS RELEASE

TELA Bio Reports Second Quarter 2025 Financial Results

TELA Bio Reports Second Quarter 2025 Financial Results MALVERN, Pa., Aug. 11, 2025 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA Bio"), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions, today reported financial results for the second quarter ended June 30, 2025. Recent Highlights Delivered revenue of $20.2 million in the second quarter 2025, representing growth of 26% over the prior year period and sequential growth of 9% over the first quarter of 2025;Increased demand for OviTex® and OviTex PRS Reinforced Tissue Matrix produ...

 PRESS RELEASE

TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)...

TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) MALVERN, Pa., Aug. 08, 2025 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA Bio") (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions, today announced that the Compensation Committee of the Board of Directors of TELA Bio approved inducement grants of restricted stock units covering 10,200 shares of its common stock to fourteen newly-hired employees, with a grant date of August 5, 2025 (the "Grant Date"). The restricted stock units were granted ...

 PRESS RELEASE

Synaptics Reports Fourth Quarter and Full Year Fiscal 2025 Results

Synaptics Reports Fourth Quarter and Full Year Fiscal 2025 Results Fiscal 2025 revenue grew 12.0%, fueled by 53% growth in Core IoT product sales Synaptics' Board of Directors approved a new share repurchase program of up to $150 million Fiscal 2025 Financial Highlights Revenue of $1.074 billion increased 12% year-over-yearCore IoT product sales grew by 53% year-over-yearGAAP loss per share of $1.22Non-GAAP diluted earnings per share increased 61% to $3.62Repurchased $128 million (or approximately 1.8 million) sharesReduced gross debt by approximately 14% or $134 million Q4’25 Financial...

 PRESS RELEASE

Synaptics To Participate at Upcoming Investor Conference Monday, Augus...

Synaptics To Participate at Upcoming Investor Conference Monday, August 11, 2025 SAN JOSE, Calif., Aug. 06, 2025 (GLOBE NEWSWIRE) -- Synaptics® Incorporated (Nasdaq: ) today announced its participation in the upcoming investor conference. Rahul Patel, President & Chief Executive Officer, and Ken Rizvi, CFO, will present at the KeyBanc Capital Markets’ Technology Leadership Forum on Monday, August 11, 2025, at 10:00 AM PT. To view the webcast or access a replay, please visit About Synaptics Incorporated: Synaptics (Nasdaq: ) is driving innovation in AI at the Edge, bringing AI close...

 PRESS RELEASE

Middlefield Banc Corp. Announces Additions to Banking Team

Middlefield Banc Corp. Announces Additions to Banking Team John Cunningham appointed Northeast Ohio Commercial Market ExecutiveThomas Young appointed Northeast Ohio Commercial Relationship ManagerNick Paradiso appointed Central Ohio Commercial Relationship ManagerMiddlefield also announces the retirement of Jack Gregorin Northeast Ohio Commercial Relationship Manager MIDDLEFIELD, Ohio, July 31, 2025 (GLOBE NEWSWIRE) -- Middlefield Banc Corp. (NASDAQ: MBCN) today announced that John Cunningham has been appointed Northeast Ohio Commercial Market Executive, Thomas Young has been appointed N...

 PRESS RELEASE

American Assets Trust, Inc. Reports Second Quarter 2025 Financial Resu...

American Assets Trust, Inc. Reports Second Quarter 2025 Financial Results Net income available to common stockholders of $5.5 million and $48.0 million for the three and six months ended June 30, 2025, respectively, or $0.09 and $0.79 per diluted share, respectively. Funds from Operations ("FFO") excluding lease termination fees and litigation income of $0.51 and $1.03 per diluted share for the three and six months ended June 30, 2025, respectively, compared to $0.60 and $1.19 per diluted share for the same periods in 2024. Increased 2025 FFO per diluted share guidance to a range of ...

 PRESS RELEASE

Donegal Group Inc. Announces Second Quarter and First Half 2025 Result...

Donegal Group Inc. Announces Second Quarter and First Half 2025 Results MARIETTA, Pa., July 24, 2025 (GLOBE NEWSWIRE) -- Donegal Group Inc. (NASDAQ: DGICA) and (NASDAQ: DGICB) today reported its financial results for the second quarter and first half of 2025. Significant Items for Second Quarter of 2025 (all comparisons to second quarter of 2024): Net premiums earned decreased 1.1% to $231.8 millionCombined ratio of 97.7%, compared to 103.0%Net income of $16.9 million, or 46 cents per diluted Class A share, compared to $4.2 million, or 13 cents per diluted Class A shareNet investment ga...

 PRESS RELEASE

TELA Bio to Participate in the Canaccord Genuity 45th Annual Growth Co...

TELA Bio to Participate in the Canaccord Genuity 45th Annual Growth Conference MALVERN, Pa., July 23, 2025 (GLOBE NEWSWIRE) -- TELA Bio, Inc. (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions, today announced that the Company will participate in the Canaccord Genuity 45th Annual Growth Conference. TELA’s management is scheduled to present at the Canaccord Genuity 45th Annual Growth Conference at 10:00 am ET on August 13th, 2025. Interested parties can access the live and archived webcast at . About TELA Bio...

 PRESS RELEASE

Middlefield Banc Corp. Reports 2025 Six-Month Financial Results

Middlefield Banc Corp. Reports 2025 Six-Month Financial Results MIDDLEFIELD, Ohio, July 22, 2025 (GLOBE NEWSWIRE) -- Middlefield Banc Corp. (NASDAQ: MBCN) today reported financial results for the six months ended June 30, 2025. 2025 Second-Quarter Financial Highlights (on a year-over-year basis):  ●Earnings per share increased 46.2% year-over-year to $0.76 per diluted share ●Asset quality improved from the 2024 fourth quarter with nonperforming assets to total assets decreasing by 32 basis points to 1.30% ●Net interest margin expanded 37 basis points to 3.88% and increased 19 basis point...

 PRESS RELEASE

TELA Bio to Announce Second Quarter 2025 Financial Results

TELA Bio to Announce Second Quarter 2025 Financial Results MALVERN, Pa., July 21, 2025 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA Bio") (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions, today announced that the Company will report second quarter 2025 financial results on Monday, August 11, 2025. TELA Bio’s management will host a conference call and webcast at 4:30 p.m. ET that day to discuss the financial results and provide a corporate update. Second Quarter Earnings Conference Call and Webcast DetailsInves...

 PRESS RELEASE

Donegal Group Inc. Announces Quarterly Dividend

Donegal Group Inc. Announces Quarterly Dividend MARIETTA, Pa., July 17, 2025 (GLOBE NEWSWIRE) -- Donegal Group Inc. (NASDAQ:DGICA) and (NASDAQ:DGICB) reported today that its board of directors declared a regular quarterly cash dividend of $0.1825 per share of the Company’s Class A common stock and $0.165 per share of the Company’s Class B common stock. The dividends are payable on August 15, 2025 to stockholders of record as of the close of business on August 1, 2025. About Donegal Group Inc. Donegal Group Inc. is an insurance holding company whose insurance subsidiaries and affiliates ...

 PRESS RELEASE

Synaptics to Report Fourth Quarter and Full Year Fiscal 2025 Results o...

Synaptics to Report Fourth Quarter and Full Year Fiscal 2025 Results on August 7, 2025 SAN JOSE, Calif., July 16, 2025 (GLOBE NEWSWIRE) -- Synaptics® Incorporated (Nasdaq: ) today announced that it will report financial results for the fourth quarter and full year of fiscal 2025 on Thursday, August 7, 2025, after the market closes. The Company will host a corresponding conference call for analysts and investors at 2:00 p.m. PT (5:00 p.m. ET), to discuss the results. To participate on the live call, analysts and investors should pre-register at . Registrants will receive ...

 PRESS RELEASE

American Assets Trust, Inc. Announces Second Quarter 2025 Earnings Rel...

American Assets Trust, Inc. Announces Second Quarter 2025 Earnings Release Date and Conference Call Information SAN DIEGO, July 07, 2025 (GLOBE NEWSWIRE) -- American Assets Trust, Inc. (NYSE:AAT) (the “Company”) will announce its second quarter 2025 earnings in a press release to be issued after the market closes on Tuesday, July 29, 2025. Senior management will hold a conference call for its second quarter 2025 earnings on Wednesday, July 30, 2025 at 8:00 a.m. Pacific Time (“PT”). To access the conference call, please dial 1 (833) 816-1162 and ask to join the American Assets Trust, Inc...

 PRESS RELEASE

Donegal Group Inc. Announces Release Date for Second Quarter 2025 Resu...

Donegal Group Inc. Announces Release Date for Second Quarter 2025 Results MARIETTA, Pa., July 02, 2025 (GLOBE NEWSWIRE) -- Donegal Group Inc. (NASDAQ:DGICA) and (NASDAQ:DGICB) announced today that it plans to release its results for second quarter ended June 30, 2025, on Thursday, July 24, 2025, before the opening of regular trading on the NASDAQ Stock Market. The Company will provide a supplemental investor presentation in the Investors section of its website at , concurrently with its earnings press release. At approximately 8:30 am ET on Thursday, July 24, 2025, the Company will mak...

Calumet Inc: 2 directors

Two Directors at Calumet Inc sold 175,123 shares at between 15.847USD and 16.690USD. The significance rating of the trade was 71/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the las...

 PRESS RELEASE

TELA Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(...

TELA Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) MALVERN, Pa., June 06, 2025 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA Bio") (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's own anatomy, today announced that the Compensation Committee of the Board of Directors of TELA Bio approved inducement grant of an option to purchase 75,000 shares of its common stock and restricted stock units coveri...

 PRESS RELEASE

TELA Bio Announces European Commercial Launch of OviTex® Inguinal for ...

TELA Bio Announces European Commercial Launch of OviTex® Inguinal for Robotic and Laparoscopic Inguinal Hernia Repair Based on market research, inguinal hernia repair is the most common type of hernia repair MALVERN, Pa., June 03, 2025 (GLOBE NEWSWIRE) -- . (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions, today announced the European launch of OviTex Inguinal Reinforced Tissue Matrix, the only reinforced tissue matrix specifically engineered for laparoscopic and robotic-assisted inguinal hernia repair. T...

Moody's Ratings assigns Ba1 rating to Rocket Companies, Inc.'s new sen...

Moody's Ratings (Moody's) has assigned a Ba1 long-term senior unsecured rating to Rocket Companies, Inc.'s (Rocket) new $4.0 billion backed senior unsecured notes and affirmed Rocket Mortgage, LLC's Ba1 long-term senior unsecured rating. We have also assigned a Ba1 corporate family rating (CFR) to R...

Loading...
New interest

Save your current filters as a new Interest

Please enter a name for this interest

Email alerts

Would you like to receive real-time email alerts when a new report is published under this interest?

Save This Search

These search results will show up under 'Saved searches' in the left panel

Please enter a name for this saved search

ResearchPool Subscriptions

Get the most out of your insights

Get in touch